Top 50 Health Care VC Funds & Investors in Germany (September 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
HTGF (High-Tech Gruenderfonds)
VC Fund
|
129 | Germany, Switzerland, United States | Seed, Series A | Software, Biotechnology, Information Technology | $850k–$31M |
|
IBB Ventures
VC Fund
|
44 | Germany, United States, United Kingdom | Seed, Series A | Software, Health Care, SaaS | $1M–$11M |
|
Bayern Kapital
VC Fund
|
41 | Germany, United States, Finland | Seed, Series A | Software, Health Care, Information Technology | $1.7M–$32M |
|
Atlantic
VC Fund
|
35 | Germany, Switzerland, United States | Seed, Pre-Seed, Series A | Software, Health Care, Artificial Intelligence | $850k–$30M |
|
TGFS - Technologiegründerfonds Sachsen
VC Fund
|
27 | Germany, United States | Seed, Series A | Software, Information Technology, Manufacturing | $796k–$15M |
|
Calm/Storm VC
VC Fund
|
24 | United Kingdom, Germany, Austria | Seed, Pre-Seed, Series A | Health Care, Wellness, Software | $538k–$18M |
|
Think.Health
VC Fund
|
24 | Germany, United States, France | Seed, Series A, Series B | Health Care, Biotechnology, Medical Device | $1.1M–$28M |
|
NRW.BANK
VC Fund
|
22 | Germany, United States, France | Seed, Series A, Series B | Information Technology, Software, Biotechnology | $219k–$71M |
|
HV Capital
VC Fund
|
22 | Germany, United States, United Kingdom | Series A, Seed, Series B | E-Commerce, Software, Internet | $1.5M–$80M |
|
KfW
VC Fund
|
21 | Germany, India, United Kingdom | Series A, Series B | Biotechnology, Software, Health Care | $2.2M–$17M |
|
DvH Ventures
VC Fund
|
20 | Germany, Austria, United Kingdom | Seed, Series A | Health Care, Software, Financial Services | $1M–$19M |
|
Antler
VC Fund
|
19 | Singapore, Australia, United Kingdom | Pre-Seed, Seed, Series A | Software, Artificial Intelligence, Information Technology | $100k–$29M |
|
APX
VC Fund
|
19 | Germany, United Kingdom, United States | Pre-Seed, Seed, Series A | Software, SaaS, Information Technology | $55k–$15M |
|
b2venture
VC Fund
|
18 | Germany, Switzerland, United Kingdom | Series A, Seed, Series B | Software, Health Care, Information Technology | $1.4M–$52M |
|
Rheingau Founders
VC Fund
|
17 | Germany, United States, Poland | Seed, Series A, Pre-Seed | Software, E-Commerce, Internet | $627k–$14M |
|
bmp Ventures
VC Fund
|
17 | Germany, United States, Austria | Seed, Series A | Software, Information Technology, Manufacturing | $162k–$5.9M |
|
bm-t beteiligungsmanagement thuringen
VC Fund
|
17 | Germany, United States | Seed, Series A | Software, Health Care, Information Technology | $461k–$10M |
|
Boehringer Ingelheim Venture Fund
VC Fund
|
17 | United States, Germany, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $1.8M–$50M |
|
Brandenburg Kapital
VC Fund
|
16 | Germany, United Kingdom | Seed, Series A, Venture - Series Unknown | Health Care, Software, Information Technology | $873k–$13M |
|
Heal Capital
VC Fund
|
16 | Germany, United Kingdom, France | Seed, Series A, Pre-Seed | Health Care, Artificial Intelligence, Machine Learning | $1M–$35M |
|
Wellington Partners
VC Fund
|
16 | Germany, United States, United Kingdom | Series A, Series B, Series C | Health Care, Biotechnology, Medical | $3.3M–$100M |
|
MIG Capital
VC Fund
|
15 | Germany, France, Austria | Series A, Series B, Seed | Biotechnology, Health Care, Software | $1.3M–$60M |
|
Saarbruecker 21
VC Fund
|
15 | Germany, United States, Israel | Seed, Pre-Seed, Angel | Software, Internet, E-Commerce | $219k–$5.9M |
|
IFB Innovationsstarter
VC Fund
|
14 | Germany, United States | Seed, Grant | Software, SaaS, Artificial Intelligence | $79k–$3M |
|
BayBG Venture Capital
VC Fund
|
13 | Germany, Italy, United States | Series A, Series B | Software, Information Technology, Health Care | $732k–$21M |
|
Ananda Impact Ventures
VC Fund
|
13 | Germany, United Kingdom, Finland | Seed, Series A, Series B | Health Care, Software, Information Technology | $1.6M–$53M |
|
YZR Capital
VC Fund
|
12 | Germany, United Kingdom, Poland | Seed, Pre-Seed, Series A | Health Care, Medical, Artificial Intelligence | $742k–$52M |
|
Auxxo
VC Fund
|
12 | Germany, United Kingdom, France | Seed, Pre-Seed, Series A | Software, Health Care, FinTech | $1.1M–$14M |
|
seed + speed Ventures
VC Fund
|
12 | Germany, Austria, Switzerland | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, SaaS | $625k–$20M |
|
redalpine
VC Fund
|
12 | Germany, Switzerland, United Kingdom | Seed, Series A, Series B | Biotechnology, Health Care, Software | $1.6M–$125M |
|
Springboard Health Angels
VC Fund
|
11 | Germany, United States, Switzerland | Seed, Pre-Seed | Health Care, Medical, Software | $400k–$5.8M |
|
Vorwerk Ventures
VC Fund
|
11 | Germany, United Kingdom, Denmark | Seed, Series A, Series B | E-Commerce, Health Care, Software | $3.3M–$80M |
|
BioMedPartners
VC Fund
|
11 | Switzerland, Germany, France | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $5.3M–$75M |
|
468 Capital
VC Fund
|
11 | United States, Germany, Singapore | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Information Technology | $500k–$42M |
|
Heartcore Capital
VC Fund
|
11 | Denmark, United States, Germany | Seed, Series A, Series B | Software, Artificial Intelligence, FinTech | $1.2M–$58M |
|
TechVision Fund
VC Fund
|
10 | Germany, Spain | Seed, Series A, Pre-Seed | Software, Health Care, Manufacturing | $1.2M–$28M |
|
Cherry Ventures
VC Fund
|
10 | Germany, United Kingdom, United States | Seed, Series A, Series B | Software, Information Technology, Financial Services | $1.9M–$117M |
|
Picus Capital
VC Fund
|
10 | Germany, United States, United Kingdom | Seed, Series A, Pre-Seed | Financial Services, Software, FinTech | $563k–$33M |
|
Target Global
VC Fund
|
10 | Germany, United States, Israel | Series A, Seed, Series B | Software, FinTech, Financial Services | $2M–$100M |
|
Flixfounders
VC Fund
|
9 | Germany, Israel, Luxembourg | Seed, Series A, Pre-Seed | Software, Information Technology, Artificial Intelligence | $543k–$34M |
|
better ventures
VC Fund
|
9 | Germany, Switzerland | Pre-Seed, Seed, Series A | Software, Food and Beverage, E-Commerce | $1.1M–$6.9M |
|
Redstone.VC
VC Fund
|
9 | Germany, Finland, Switzerland | Seed, Series A, Pre-Seed | Software, Information Technology, Artificial Intelligence | $460k–$17M |
|
BONVENTURE
VC Fund
|
9 | Germany, Austria, Estonia | Seed, Series A | Health Care, Software, SaaS | $980k–$19M |
|
Capacura
VC Fund
|
9 | Germany | Seed, Pre-Seed, Venture - Series Unknown | Health Care, Recycling, Software | $505k–$2.9M |
|
coparion
VC Fund
|
9 | Germany, Switzerland, United States | Series A, Seed, Series B | Software, SaaS, FinTech | |
|
Amino Collective
VC Fund
|
8 | United States, United Kingdom, Germany | Seed, Series A, Pre-Seed | Biotechnology, Health Care, Artificial Intelligence | $125k–$37M |
|
Creathor Ventures
VC Fund
|
8 | Germany, Switzerland, United States | Series A, Series B | Software, Health Care, Biotechnology | $2M–$30M |
|
Earlybird Venture Capital
VC Fund
|
8 | Germany, United States, United Kingdom | Series A, Seed, Series B | Software, Information Technology, Artificial Intelligence | $1.5M–$75M |
|
Possible Ventures
VC Fund
|
7 | Germany, Australia, United States | Seed, Pre-Seed, Series A | Software, Biotechnology, Information Technology | $549k–$47M |
|
BM H Beteiligungs-Managementgesellschaft Hessen
VC Fund
|
7 | Germany | Seed, Series A, Pre-Seed | Software, SaaS, Artificial Intelligence | $605k–$9.3M |
| Access all 1686 VC funds in Germany Health Care startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in varioussectors.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Series A
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 739
- Round size: Seed $850k–$7M; Series A $3.1M–$31M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely still investing — raised $515M in 2022
Portfolio highlights
- Zimory — Founded in 2007, Zimory provides carrier-grade cloud infrastructure management software that allows service providers, enterprises and cloud brokers to fully leverage the power and elasticity of cloud computing. Zimory’s intelligent Cloud Suite simplifies, automates and expedites the creation, launch and management of all types of cloudenvironments – whether public, private, virtual private or hybrid. Zimory software is also a key enabler of cloud marketplaces for enterprise services, applications and infrastructure. Headquartered in Berlin, Zimory has development centers in Erfurt, Germany and Minsk, Belarus, a subsidiary office in New York City and is expanding its expertise and presence globally.
- Alteva — Alteva develops battery cells for the decarbonisation of the global transport sector, and focus on high-energy density battery cells with high safety profiles specifically designed for the aviation and heavy-duty transport sectors.
- Smartblue — Smartblue develops and runs software and processes to monitor and optimize zero emission energy systems. As a hardware independent specialist Smartblue delivers a software service for the maintenance, life-cycle management, production forecasting and remote control of photovoltaic and energy storage systems all together in one centralized “SmartControl” Operations and Control Center web application. We help our customers drive down overall operational cost through automation, smart failure detection and big data analysis on imminent defects.
Pre-Seed to Series A for Berlin-based founders. Where 30 years of expertise, capital and execution power meet.
Show more...Investment focus
- Industry: Software, Health Care, SaaS
- Stage:Seed, Series A
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 260
- Round size: Seed $1M–$4.6M; Series A $2.3M–$11M
- Lead/follow: 20% lead, 80% follow
- Last fund: Likely still investing — raised $120M in 2022
Portfolio highlights
- Nenna AI — Nenna AI is a powerful AI enablement platform designed for the secure application of AI technologies.
- Jurafuchs — Jurafuchs provides legal education via a mobile app.
- AERLIN — AERLIN GmbH is an innovative aerospace technology company based in Berlin, Germany, focused on designing and manufacturing a next-generation flying-wing aircraft platform. The company aims to transform regional and light aviation by moving away from traditional tube-and-wing designs. Instead, they use a highly efficient airframe architectureinspired by the aerodynamic principles of the albatross. Their scalable platform is engineered to support clean propulsion technologies—including Sustainable Aviation Fuels (SAF), hybrid systems, and battery-electric power—without compromising payload volume, cruise range, or passenger comfort.
Bayern Kapital (founded at the end of 1995) is a wholly owned subsidiary of the LfA Foerderbank Bayern (Bavaria‘s development bank). Bayern Kapital’s objective is to finance research and development as well as the market launch of new products, product diversifications, and expansion of the market share.The requesting company has to be located inBavaria. Industries are e. g. IT/software, life sciences, new materials, micro-systems and environmental technologies.Bayern Kapital and its funds have invested in more than 250 companies and currently manages funds to the value of EUR 340 m. The five investing funds currently managed by Bayern Kapital are Seedfonds Bayern, Clusterfonds Start-Up!, Innovationsfonds, Innovationsfonds EFRE and Wachstumsfonds Bayern.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Series A
- Geography: Germany, United States, Finland
Investor stats
- Total investments: 255
- Round size: Seed $1.7M–$5.9M; Series A $3.9M–$32M
- Lead/follow: 15% lead, 85% follow
- Last fund: May invest from a new fund soon — raised $29M in 2010
Portfolio highlights
- Hema.to — Flow cytometry analysis software, re-imagined. From raw FCS and LMD data to finalized report with AI-powered CellStudio.
- 4.screen — The Driver Interaction Platform. Connect with drivers in real-time to deliver personalized and targeted campaigns.
- inContAlert — inContAlert is a deep tech start-up disrupting the field of incontinence. The technology of inContAlert helps people with bladder dysfunction to monitor the filling level of their urinary bladder.inContAlert, therefore, developed an mHealth device, which collects and analyzes data with the help of deep learning algorithms. The information is thendisplayed on an app and sends an alert to incontinence patients when a predefined filling level is reached. inContAlert thereby minimizes the risk of an uncontrolled loss of urine or the harmful distension of the bladder. With the help of inContAlert, incontinence patients can go back to normal and live a carefree life.
Atlantic Labs supports and invests in mission-driven founders working on transformative technology ventures. <br><br>We partner with founders early, providing the capital, tools and network necessary to growing their companies and accompanying them on their entrepreneurial journey. We are currently active in areas including Digital Health, Future of Work, Machine Learning, Decentralized Networks, Mobility and Industrial Applications.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 263
- Round size: Seed $1.2M–$9.4M; Pre-Seed $850k–$3.5M; Series A $4.6M–$30M
- Lead/follow: 45% lead, 55% follow
- Last fund: Likely still investing — raised $110M in 2022
Portfolio highlights
- Stenon — Stenon is a laboratory independent real-time soil analyst that offers solutions for agriculture.
- 42matters — 42matters offers a full suite of mobile and connected TV app intelligence solutions, including APIs, file dumps, and visual, web-based platforms.
- Phase0 — Payment platform for construction projects
TGFS - Technologiegruenderfonds Sachsen is an early stage VC fund targeting high tech startups with strong growth potential. The fund invests into ventures located in Saxony/Germany, Europe's leading semiconductor cluster. The team has invested into more than 120 companies so far, including more than 40 investments from the currentfund.
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Seed, Series A
- Geography: Germany, United States
Investor stats
- Total investments: 159
- Round size: Seed $796k–$4.8M; Series A $1.9M–$15M
- Lead/follow: 23% lead, 77% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Prodlane — Prodlane, the company behind MAIA, is a technology company based in Leipzig that specializes in intelligent software solutions for SMEs in the DACH region. With MAIA, we are setting new standards in data analysis and daily knowledge management in all areas of the company using AI, thereby driving forward the digital transformation of SMEs.
- Cyber Insight — Cyber Insight - Measure, Manage, Mitigate Cyber Risks
- HandsOn Robotics — Handson Robotics provides state of the art robotics automation workflows for commercial kitchens.
Calm/Storm is an exclusive founder network and venture capital firm. We invest in purpose driven founders changing our life & health for the better. Headquartered in Vienna, Austria we invest in early-stage companies all over Europe and the US. We focus on the pre-seed and seed stages but also invest up to Series A.
Show more...Investment focus
- Industry: Health Care, Wellness, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, Germany, Austria
Investor stats
- Total investments: 143
- Round size: Seed $1.1M–$6.3M; Pre-Seed $538k–$2.6M; Series A $7.6M–$18M
- Lead/follow: 8% lead, 92% follow
- Last fund: Likely still investing — raised $25M in 2023
Portfolio highlights
- PROPCORN AI — At PROPCORN, our goal is to harness the power of AI to automatically unlock the full real estate building potential of our customers, enabling them to make faster and more accurate decisions in real-time.
- SquareMind — SquareMind redefines skin exams with Swan, the world's first full-body dermoscopy robot. Automated, seamless, and powered by AI technology.
- aeon.life — Preventive healthcare platform that equips people with personalized insights and expert guidance for proactive whole-body health
Think.Health invests as a boutique risk-taker in healthcare ventures. We continuously seek innovations and disruptive business models in digital healthcare, medical technologies and health service providers,
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Seed, Series A, Series B
- Geography: Germany, United States, France
Investor stats
- Total investments: 36
- Round size: Seed $1.1M–$7.6M; Series A $3.8M–$28M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Robeaute — Redesigning the future of neurosurgery by creating the new standard device that will provide surgeons with seamless access to delicate areas of the brain parenchyma and with real-time data.
- Inflammatix — Inflammatix develops rapid point of care diagnostic tests by reading the immune system, and resolves major clinical health challenges.
- Sphingotec GmbH — Improving patient outcomes with innovative diagnostics for critical care: Actionable insights in real-time
NRW.BANK is the development bank for the state of North Rhine-Westphalia. It supports its owner – the state of North Rhine-Westphalia – in fulfilling its tasks, notably in the fields of structural, economic, social and housing policy. NRW.BANK pools the promotion and development programmes of the state of North Rhine-Westphalia, the FederalRepublic of Germany and the European Union and combines them with its own equity and debt products and advisory services. It offers the full range of financial products in three areas “Economy”, “Housing”, and “Infrastructure/Municipalities”. NRW.BANK operates in a competitively neutral manner as a partner of banks and savings banks.
Show more...Investment focus
- Industry: Information Technology, Software, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: Germany, United States, France
Investor stats
- Total investments: 136
- Round size: Seed $219k–$7.7M; Series A $2.4M–$36M; Series B $3.8M–$71M
- Lead/follow: 24% lead, 76% follow
- Last fund: Likely still investing — raised $163M in 2023
Portfolio highlights
- skylance — Skylance develops counter-unmanned aerial systems for military and public-security users. Its products include close-range kinetic interceptors designed for Class 1 drones and a modular launcher that supports shoulder-mounted, tripod, and vehicle-integrated configurations. The company describes its systems as software-defined and compatible withexisting command-and-control structures. Its stated operating range for close-range interception is 100 to 1,200 meters.
- OMMM — OMMM Operations Management Solutions is a software house that specializes in the digitization and automation of industrial planning.
- PhageStack — PhageStack GmbH develops a computational platform that applies machine learning to screen, identify, and analyze specific bacteriophages. This technical infrastructure is built to help research partners accelerate the discovery of targeted biological options against antibiotic-resistant bacteria.
HV Capital is one of the leading early-stage and growth investors in Europe. With nine fund generations in 23 years and €2.8 bn in managed assets, HV Capital is one of the continent's most active investors. The investment team has many years of experience in identifying European startups with great potential for success. In addition tointernational success stories like Zalando, Delivery Hero, Sumup, and Depop, innovation leaders such as Enpal, Flixbus, Sennder, and Isar Aerospace are also part of the portfolio. HV Capital has invested in around 225 internet and technology companies, supporting startups with ticket sizes ranging from €0.5 to €60m. It is one of Europe's few venture capital firms that can finance startups through all growth phases. HV Capital has a team of more than 40 investment and operations professionals who provide a variety of perspectives and expertise across the venture capital landscape.
Show more...Investment focus
- Industry: E-Commerce, Software, Internet
- Stage:Series A, Seed, Series B
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 506
- Round size: Seed $1.5M–$12M; Series A $3.3M–$37M; Series B $7.7M–$80M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely still investing — raised $783M in 2023
Portfolio highlights
- Exein — Exein develops embedded cybersecurity solutions designed to secure Internet of Things (IoT) and connected devices. The company provides a platform that integrates security directly into the firmware of embedded systems, enabling real-time threat detection, monitoring, and response. Exein’s technology focuses on runtime protection and behavioranalysis at the edge, helping manufacturers secure devices without requiring major hardware changes or external software agents. Its solution is compatible with widely used real-time operating systems (RTOS) and Linux-based environments, allowing for flexible integration across different devices. The company also offers tools for vulnerability assessment and threat intelligence tailored for firmware-level defense. Exein supports developers with APIs and SDKs to incorporate security features during the product development phase. Through its platform, the company addresses growing security risks in critical sectors such as automotive, industrial automation, and consumer electronics.
- Flip — The AI employee experience platform for frontline workers without a company email. Flip unites comms, HR, identity and AI in one app. Book a demo.
- Ore Energy — Ore Energy is creating a new generation, cost effective, long-duration energy storage solution which will enable a decarbonized energy future by utilizing some of the most readily available materials
KfW gives impetus to economic, social and ecological development worldwide. As a promotional bank under the ownership of the Federal Republic and the Länder (federal states), it offers support to encourage sustainable improvement in economic, social, ecological living and business conditions, among others in the areas of small and medium-sizedenterprise, entrepreneurialship, environmental protection, housing, infrastructure, education finance, project and export finance, and development cooperation.
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Series A, Series B
- Geography: Germany, India, United Kingdom
Investor stats
- Total investments: 162
- Round size: Series A $2.2M–$7.5M; Series B $3.3M–$17M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Andercore — Andercore connects global suppliers and local buyers on one AI-driven platform, automating inventory selection, pricing, quotes, financing and global distribution at scale.
- AtlasEdge — Empowering a sustainable digital society by enabling infrastructure where it is needed.
- Quantum Systems — Our vision is to become the global leader in providing aerial data for decision making by the use of our drones.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investing early in Europe's most passionate founders.
Show more...Investment focus
- Industry: Health Care, Software, Financial Services
- Stage:Seed, Series A
- Geography: Germany, Austria, United Kingdom
Investor stats
- Total investments: 104
- Round size: Seed $1M–$7.9M; Series A $3.8M–$19M
- Lead/follow: 37% lead, 63% follow
- Last fund: May invest from a new fund soon — raised $70M in 2020
Portfolio highlights
- Dermanostic — Dermanostic is an e-health app where patients receive a medical diagnosis and therapy recommendation for skin diseases.
- Dr. Vivien Karl — Dr. Vivien Karl is an intimate care company. Dr. Vivien Karl provides science based products for effective and safe intimate care. Their products include cream for moisturizing and caring for the intimate area.
- microsynetics GmbH — Developing hardware and software to help elderly people gaining more freedom and quality of life. Our first product is an emergency wristband which works together with an app, also connecting relatives via smartphone and phone integrated in the emergency wristband. The automated AI-based fall detection guarantees help even when the user - afteraccident - isn't capable anymore of activating the emergency call via integrated button.
Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Pre-Seed, Seed, Series A
- Geography: Singapore, Australia, United Kingdom
Investor stats
- Total investments: 2377
- Round size: Seed $158k–$4.5M; Pre-Seed $100k–$590k; Series A $4.1M–$29M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely actively investing — fresh fund, raised $7.5M in 2026
Portfolio highlights
- Two — Buy Now, Pay Later for your business customers. Two makes it easy and safe to offer invoice as a payment method on your e-commerce site.
- Forti Foods — The mission of Forti Foods is to enhance communities and change lives beyond the plate by fostering resilience and dignity via sustainable food innovation.
- Neighbourhood — Neighbourhood transform unused spaces in restaurants, hotels and residences, into local hubs for co-working, creating and collaborating.
APX is Europe’s leading very-early-stage VC. Based in Berlin and backed by Axel Springer and Porsche, we support and partner with the most ambitious founding teams from Europe and beyond - often as their first investor.We invest up to EUR 500K in startups until a series A starting with a quick EUR 50K investment, and within a few months,depending on traction and speed, we can invest further. Each month we invest in new teams who become part of the APX community, counting hundreds of other founders. Since 2018, we have invested in 100+ startups across 20+ industries with founders from 20+ countries together with 100+ co-investors.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Pre-Seed, Seed, Series A
- Geography: Germany, United Kingdom, United States
Investor stats
- Total investments: 211
- Round size: Seed $1M–$5M; Pre-Seed $55k–$1.4M; Series A $2.1M–$15M
- Lead/follow: 28% lead, 72% follow
- Last fund: May invest from a new fund soon — raised $67M in 2021
Portfolio highlights
- VisioLab — Instantly scan products for self-checkout, using the iPad camera - no barcodes needed. Designed for speed, simplicity and human centricity.
- Bloom — Moved to @bloomsocial
- Track Titan — Titan Academy revolutionises how gamers improve through fully automated coaching.
B2venture is a venture capital firm focused on early-stage investments in digital and industrial technology companies. B2venture invests EUR 100m+ per year in high-growth companies with ticket sizes from EUR 0.25m to 3.5m.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Series A, Seed, Series B
- Geography: Germany, Switzerland, United Kingdom
Investor stats
- Total investments: 272
- Round size: Seed $1.4M–$8.8M; Series A $3.4M–$23M; Series B $6.9M–$52M
- Lead/follow: 28% lead, 72% follow
- Last fund: Likely actively investing — fresh fund, raised $179M in 2026
Portfolio highlights
- Everlab — The preventative health service of the future. Detect disease early, improve wellbeing, and optimise performance.
- Flyboard — Human-level AI voice agents at a fraction of the cost. Transform your customer engagement with intelligent automation.
- Kiin Bio — Accelerate drug discovery with Virtual Scientists. Unified platform integrating 100+ specialized tools into one intelligent workflow.
Rheingau Founders is a Berlin&Munich based Venture Capital firm active since 2011. Focusing on pre-seed to Series A investments in Europe, predominantly B2B in the fields of Marketplaces, Software as a Service, InsurTech, and eHealth. Rheingau targets start-ups that have the potential to sustainably disrupt existing processes and value chains.Besides the financial investment, we offer strategic support through the mentorship of our partners.
Show more...Investment focus
- Industry: Software, E-Commerce, Internet
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, United States, Poland
Investor stats
- Total investments: 88
- Round size: Seed $627k–$6.3M; Pre-Seed $770k–$2.7M; Series A $2.7M–$14M
- Lead/follow: 28% lead, 72% follow
Portfolio highlights
- MoleQlar — MoleQlar is a data and research-driven longevity company. It provides valuable information and offers consumers lab-tested nutritional supplements. The company focuses on functional medicine with optimized nutrition. Their product range includes Uthever NMN, Resveratrol, Betaine, Carnosine, and more. These products are aimed at lowering biologicalage and promoting health and longevity. MoleQlar also offers health tracking services. The company is certified in Germany and delivers its products EU-wide, including Switzerland.
- Qualifyze — Qualifyze (former ChemSquare) was founded out of the Technical University of Darmstadt in September 2017. Today, we are based in Frankfurt am Main, the heart of Germany’s pharmaceutical cluster, where the leading life science companies are based. Our team consists of 16 people with diverse backgrounds and areas of expertise in business,engineering, and technology as well as several strategic partners from the pharma, food and cosmetics industry.
- Akhetonics — Akhetonics is a photonic computing company building all-optical processors for ultra-fast AI and high-performance computing. It is a deep-tech semiconductor company focused on photonic (light-based) computing hardware. It develops all-optical processors designed to accelerate AI, reasoning, and complex computational workloads. The company aims todeliver ultra-fast, energy-efficient computing beyond traditional electronic chips.
bmp Ventures is an innovative Venture Capital Company from Berlin. Since 1997 we’ve been investing Smart Money in Early Stage and Growth Startups. We finance ingenious business models with outstanding teams, who build fast-growing and sustainably profitable enterprises.
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Seed, Series A
- Geography: Germany, United States, Austria
Investor stats
- Total investments: 122
- Round size: Seed $162k–$3.6M; Series A $912k–$5.9M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely actively investing — fresh fund, raised $70M in 2024
Portfolio highlights
- Lab Thunder — LabThunder provides a cloud-based laboratory management software platform designed to digitize operational workflows. The system centers on centralizing equipment management, automated maintenance scheduling, digital logbooks, and AI-supported knowledge management to ensure audit-ready compliance.
- Sedivention — Fight obesity within 20 minutes - fast, effective, long-term. A new weight-loss therapy for the treatment of obesity. Just a view minutes will change your life.
- Solar Materials — Solar Materials primarily engages in the development of technologies for the sustainable and economical recycling of solar modules.
bm|t supports innovative and growth-oriented companies in Thuringia with equity investments and venture capital.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Series A
- Geography: Germany, United States
Investor stats
- Total investments: 72
- Round size: Seed $461k–$3.3M; Series A $1.2M–$10M
- Lead/follow: 60% lead, 40% follow
Portfolio highlights
- Altavo — Altavo operates as a medical device startup. Altavo harness the power of machine learning and state-of-the-art sensor technology to improve the lives of people who have lost their voice.
- Peeriot — Peeriot is a B2B software high-tech startup with a breakthrough in IoT. Peeriot offers a low-code software suite that simplifies IoT data sharing by tenfold.
- warmwind — warmwind is your all in one solution, when it comes to AI workers. No more tool chaos - everything in the cloud.
Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 108
- Round size: Seed $1.8M–$20M; Series A $3.8M–$34M; Series B $11M–$50M
- Lead/follow: 48% lead, 52% follow
- Last fund: May invest from a new fund soon — raised $250M in 2018
Portfolio highlights
- Tacalyx — Tacalyx develops therapeutics targeting cancer-specific carbohydrate antigens on the surface of metastatic malignant tumors where no satisfactory treatments exist.The name Tacalyx is derived from TACA (Tumor Associated Carbohydrate Antigen) and ‘lyx’ from the term Glycocalyx, the glycan-containing layer covering cells. Cancer cells differ fromnormal cells by displaying aberrant carbohydrate structures on their surfaces promoting metastasis, angiogenesis or suppression of the immune system. TACAs result from the aberrant glycosylation that is seen with transformation to a tumor cell and represent attractive targets for cancer treatment since they are displayed with high cancer specificity and enhance tumor virulence via the mentioned diverse mechanisms.
- smartbax — We develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
- Cloverleaf Bio — Cloverleaf Bio | Developing a new class of RNA therapeutics to revolutionize cancer therapy.
With a track record of over 20 years in venture capital and experience from more than 200 investments in numerous companies BFB Brandenburg Kapital GmbH (BFB) is the most active equity investor in Brandenburg. BFB invests in fast-growing technology-orientated companies throughout the whole life-cycle. Target sectors are ICT/Digital Economy,Life Science, MedTech, Proptech, Industrial Applications. BFB invests in companies based in or with facilities in Brandenburg. The current VC fund is financed by the European Regional Development Fund (ERDF) an Investitionsbank des Landes Brandenburg (ILB).
Show more...Investment focus
- Industry: Health Care, Software, Information Technology
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Germany, United Kingdom
Investor stats
- Total investments: 80
- Round size: Seed $873k–$6.1M; Series A $2.8M–$13M; Venture - Series Unknown $1.1M–$7.5M
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- Kupando — Kupando is a biopharmaceutical company that develops agonists to stimulates innate immunity.
- AssistMe — With a smart, adaptive and automated form of data processing and preparation, alea opens the way for future-proof, digitally supported everyday care. As an initial component of the AssistMe care platform, alea enables a contemporary, efficient care data culture for future intersectoral, networked processes and digitally supported teamwork. In theend, the aim is to effectively support care in times of a shortage of skilled workers through more self-determined content transparency - with complete personal autonomy and freedom of action and less redundancy & stress.Elderly Care will struggle in the next 10 years due to an increasing ageing population, fewer caregivers, more workload, stress, and manual documentation. All of that is a problem for the well-being of those in need of care. Furthermore, the incontinence management means large time and material expenses for caregivers. With the joint system, both companies can equip over 80 % of care recipients in care homes. An initial scientific study proved that the system could save 23 % of adult diapers and time while changing them. Together with significantly fewer leakages, the caregiver can reinvest the time gained in even higher quality care work. This ultimately has the potential to benefit care recipients in terms of quality of sleep and life. Digital functions for optimized care processesWith a very new smart sensor strip, we made leading quality adult diaper brands compatible with the digital possibilities of intelligent care technology of alea. The system reveals where care needs exist, but are not immediately visible, e.g. the urine status in the adult diaper which previously was not known until manually checked. The system transforms this initially hidden care and health data and converts it into digital, structured, immediately understandable real-time information for elderly care and its relevant stakeholders. All functionalities are based on the device alea sensor clip on smart Diaper products, which can be attached and changed in seconds. With just one quick click, caregivers turn the smart diaper into a ready-to-use digital care assistance system. With an optimal sensor position in the centre of the adult diaper and without direct skin contact. The alea hardware can generate highly valid information and make it available to care staff in real time through the mobile and web apps. The care-relevant information of alea includes the amount of urine, movements in the care bed for effective pressure ulcer prevention, fall detection and zone management. How caregivers, care homes & care recipients benefitOver 80 % of care home residents suffer from incontinence. This is a major challenge for everyone involved. The smart system solves issues for all care related audiences: Care recipients benefit from less time in full incontinence pads, but also benefit from fewer manual visual checks during bedtimes. In addition, there is a higher level of safety and prevention. By reducing time-consuming routine and visual checks on an as-needed basis. Caregivers can invest the time gained in other important or relevant care tasks. In this way, they can increase their self-determination in their work and thus their job satisfaction. Thanks to the significant savings in materials and costs, care home operators gain more planning security and can focus their business value creation even better on direct care for people in need of care. In this way, care homes can position themselves as more attractive employers for care staff because they have state-of-the-art digital equipment.With the Care. For the Care. The solution was developed and tested together with the care practice. With the IoT and future-proof platform approach, caregivers will benefit from additional functions in an established and accepted product setting. The system can be connected to various care documentation systems via open interfaces. The aim of the solution is not only to reduce the workload for all those involved in care. Care homes can also optimize teamwork and automate routine processes to support caregivers in the interests of people-centric care in the face of an increasing shortage of skilled staff. With the market entry, care homes can obtain information and order from us or one of our partners. While they order smart Diapers from our partners in the unit price context they are used to, alea Digital System comes as a software-as-a-service model. Without any additional initial costs, they can use all functions via personally provided hardware and software for each care recipient – for the most cost-efficient and needs-orientated use.
- All About Accuracy — Sub-1mm accuracy and <1ms latency RF localization for physical AI. Train robots with ground-truth motion data cameras and GPS can't reach.
Heal Capital is a European venture capital fund backing mission-driven founders with capital and HealthTech-specific expertise, accelerating market access.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Machine Learning
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, United Kingdom, France
Investor stats
- Total investments: 51
- Round size: Seed $1M–$12M; Pre-Seed $1.9M–$4M; Series A $3.7M–$35M
- Lead/follow: 53% lead, 47% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Hema.to — Flow cytometry analysis software, re-imagined. From raw FCS and LMD data to finalized report with AI-powered CellStudio.
- Aitiologic — A precision medicine startup providing multi-modal liquid biopsy solutions for early disease detection and targeted therapy.
- Tokura — Tokura focused on redesigning outpatient surgery (Ambulantes Operieren) through an integrated system of specialised facilities, experienced teams, and automated technology.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Wellington Partners is a venture capital firm that invests in technology and life sciences companies, focusing on Digital Media, Software, Electronics & Photonics, Resource Efficiency, and Biotech/Life Sciences. It is committed to providing outstanding entrepreneurs with the necessary resources to fund their strategies. We typically leadfinancing rounds ranging from € 0.5 million to € 20 million. Depending on the maturity of the company, its own commitment can go as high as € 15 million.Wellington was established in 1998 and has offices in Munich, London, and Zurich.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Series C
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 214
- Round size: Series A $3.3M–$36M; Series B $8.3M–$65M; Series C $5.5M–$100M
- Lead/follow: 30% lead, 70% follow
- Last fund: May invest from a new fund soon — raised $233M in 2019
Portfolio highlights
- nyra health — nyra health is an artificial intelligence and evidence-based neurological research tablet app that offers a revolutionary form of therapy. nyra health was founded in 2020 and was headquartered in Vienna, Austria.
- Nuclidium — NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics. Using copper isotopes, Copper-61 for diagnostics and Copper-67 for therapeutics, the company is creating a differentiated platform with the potential to overcome existing limitations in radiotheranostics.
- Beren Therapeutics — Founded to serve patients through transformative medicines
MIG Capital is one of the leading German VC Investors. We invest in European Deep Tech and Life Sciences from early to late stage (Seed, Series A, and beyond). We use investments to shape a better tomorrow, today. Our team currently manages 17 MIG public venture capital funds regulated by BaFin, the German financial markets authority. These fundsoperate with more than EUR 1.2 billion capital committed by >60,000 private investors across Germany and Austria.Today, our portfolio consists of 30 companies.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Series A, Series B, Seed
- Geography: Germany, France, Austria
Investor stats
- Total investments: 98
- Round size: Seed $1.3M–$13M; Series A $2.2M–$40M; Series B $1.7M–$60M
- Lead/follow: 45% lead, 55% follow
- Last fund: May invest from a new fund soon — raised $76M in 2014
Portfolio highlights
- NcodiN — The High Performance Computing (HPC) and ArtificiaI Intelligence (AI) era requires unprecedented computing capabilities. With this in view, industry is heading towards zettascale supercomputers, based on >100k processing units. Chiplets-based disaggregated processors and memory-centric computing architectures are taking over and require an ever more intensive communication between dies. Thus, today interconnect bottleneck is the main
- GlassPoint Solar — GlassPoint provides solar steam generators to the oil and gas industry for applications such as Enhanced Oil Recovery. It replaces gas-fired steam generation with solar, GlassPoint can reduce EOR gas consumption by up to 80 percent. The company was founded in 2008 and headquartered in Fremont, California.
- Zadient Technologies — Zadient produces semiconductor manufacturing materials that are critical for the entire silicon carbide (SiC) value chain
They are a group of friends and internet/tech entrepreneurs who first met ten years ago in Saarbruecker Strasse 21 in Berlin Prenzlauer Berg. All of them started successful businesses, they are founders and share a passion for building great companies. As active business angels, they also invest in young startups, either individually orcollectively as a group. They provide seed funding for killer-founders and great ideas. But way more important: they help to avoid mistakes that they have already made . They introduce to the right people. They provide with all the experience that they have. Not just talking about it but helping hands-on.
Show more...Investment focus
- Industry: Software, Internet, E-Commerce
- Stage:Seed, Pre-Seed, Angel
- Geography: Germany, United States, Israel
Investor stats
- Total investments: 85
- Round size: Seed $219k–$5.9M; Pre-Seed $542k–$1.6M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Floy — Floy develops AI-driven software that supports radiologists in detecting complex and hard-to-identify diseases. The collaboration of Floy-AI and radiologists ensures optimal patient outcomes by enabling the early detection and thus early treatment of diseases.One of Floy’s distinguishing features is our innovative incentive structure. We partnerwith radiology offices to jointly offer patients our AI as a “second opinion”. This unique approach motivates radiologists to embrace Floy-AI and encourages widespread adoption.Since its establishment in 2021, Floy secured €8.8 million in funding and rapidly expanded its presence with over 150 radiology locations to date. Floy’s overarching mission is to pioneer proactive medicine by providing exceptional AI-powered diagnostic experiences for health-conscious patients.
- a2zebra — a2zebra is a zebra company that specializes in instructional technology for elementary school kids.
- Meine Erde — Meine Erde is a provider of ecological burial option in Europe.
The IFB Innovationsstarter is an innovation funding and investment company of the City of Hamburg providing grants and investments.
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Seed, Grant
- Geography: Germany, United States
Investor stats
- Total investments: 90
- Round size: Seed $365k–$3M; Grant $79k–$178k
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — raised $16M in 2023
Portfolio highlights
- mo:re GmbH — We offer standardized tissue cultures and protocols to better predict drug responses and investigate disease models.
- Atrya — Atrya develops regulatory-compliant blockchain payments for international companies.
- DEALCIRCLE — DealCircle is a digital M&A solution and partner of hundreds of M&A advisors. We support in identifying buyers and addressing the market. This provides investors access to a comprehensive deal flow of relevant projects.
Innovative post-revenue startups with first customers trust us as highly reliable investors. We have been an active player in the venture capital market for over 25 years. Due to our evergreen approach, we offer institutional venture capital without the limitations of the usual fund structure. Predominantly we invest straight equity. Additionally,we can offer venture debt to mature startups close to break-even in order to avoid further dilution for founders. Being a private investment company we act as both lead investor or co-investor. We can also fulfill the private lead investor role for public investors like Bayern Kapital. Together we are increasing YOUR company's value.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Series A, Series B
- Geography: Germany, Italy, United States
Investor stats
- Total investments: 118
- Round size: Series A $1.2M–$6.4M; Series B $732k–$21M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- socialhub — Boost your social media success with SocialHub. Manage channels, schedule posts & get meaningful analytics. Try it out now!
- SPiNE — SPiNE is a startup that provides safe, clean, and inexpensive energy to all end users. It is focused on smart meter rollout and, as a result, digitalization in metering and control of charging infrastructure, heat pumps, and battery storage.
- TalentRocket — Talent Rocket is a job search engine that enables its users to find jobs with a suitable work environment for them. Job seekers can select their preferred company culture, follow their favorite companies, and start career conversations with employers. Talent Rocket was founded in 2014 and is based in London, United Kingdom.
We are the home for entrepreneurs with a big vision who want to create something less ordinary. Something that matters. For all of us.
Show more...Investment focus
- Industry: Health Care, Software, Information Technology
- Stage:Seed, Series A, Series B
- Geography: Germany, United Kingdom, Finland
Investor stats
- Total investments: 73
- Round size: Seed $1.6M–$18M; Series A $3.9M–$17M; Series B $7.3M–$53M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely actively investing — fresh fund, raised $85M in 2026
Portfolio highlights
- Aitiologic — A precision medicine startup providing multi-modal liquid biopsy solutions for early disease detection and targeted therapy.
- Decade Energy — Decade Energy is the energy infrastructure and optimization partner for transport operators and depot managers who want to electrify their fleets.
- Entelo Bio — Precision Medicine
We back ambitious HealthTech founders solving complex healthcare challenges. We provide capital, deep sector expertise, and hands-on support to build global champions.
Show more...Investment focus
- Industry: Health Care, Medical, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany, United Kingdom, Poland
Investor stats
- Total investments: 37
- Round size: Seed $2.5M–$5.5M; Pre-Seed $742k–$2.5M; Series A $10M–$52M
- Lead/follow: 59% lead, 41% follow
- Last fund: Likely still investing — raised $105M in 2022
Portfolio highlights
- Biorce — Meet the world's first AI clinical trials assistant! We bring innovative technologies to revolutionize healthcare and drug development faster & more efficiently
- dehaze — dehaze provides healthcare services by bringing medical AI models into clinical practice.
- Scan.com — Use scan.com to find the best medical imaging centers near you Find an MRI scan, CT scan, X-ray Scan, or other diagnostic imaging scan with scan.com.
The Auxxo Female Catalyst Fund is a sector agnostic pre-seed and seed stage investors that backs female-(co-)founded startups in Europe.
Show more...Investment focus
- Industry: Software, Health Care, FinTech
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany, United Kingdom, France
Investor stats
- Total investments: 50
- Round size: Seed $2.1M–$7.5M; Pre-Seed $1.1M–$2.9M; Series A $6M–$14M
- Lead/follow: 4% lead, 96% follow
- Last fund: Likely actively investing — fresh fund, raised $30M in 2025
Portfolio highlights
- NanoStruct — NanoStruct is a biotechnology company that develops nanostructured sensor chips to identify bacteria and pathogens in food.
- Resolutiion — Resolutiion provides AI-powered software for managing commercial conflict, delivery risk, and business relationship performance. The platform supports organizations with dispute detection, workflow automation, contract monitoring, issue resolution, and operational risk management across customers, suppliers, workforce teams, and commercialpartnerships. Its system uses AI-driven analysis to identify relationship friction, monitor delivery performance, and support structured resolution processes. Resolutiion also provides commercial intelligence tools, reporting, and collaboration features for enterprise delivery and governance management.
- Stanhope AI — Stanhope AI is a deep-tech startup based in London with a strong background in neuroscience, robotics and fintech. We are bringing Active Inference to market as a novel framework for autonomous decision-making. To contend with the challenges of contemporary AIs, our distinct approach aims to offer
Empowering visionary founders with pre-seed and seed funding for B2B software innovation. Partner with us to turn your aspirations into thriving businesses. Our expert support ensures your journey to success.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany, Austria, Switzerland
Investor stats
- Total investments: 87
- Round size: Seed $1.3M–$5.8M; Pre-Seed $625k–$3.9M; Series A $2.5M–$20M
- Lead/follow: 32% lead, 68% follow
- Last fund: Likely actively investing — fresh fund, raised $107M in 2026
Portfolio highlights
- Covalo — Covalo™ is disrupting how formulation-driven products are developed in the 3 trillion euro consumer goods industry so brands can reduce time to market by scouting ingredients and packaging, collaborating on projects, and purchasing -- all from one place. . Today it's one of the largest beauty ingredient search platforms that connects beautybrands with suppliers of ingredients, packaging, and services such as contract manufacturing, formulation, regulatory, compliance and testing. It also arms suppliers with the tools and real-time industry insights needed to effectively market products. Covalo launched in 2021 and is based in Switzerland.
- SOUS — One easy-to-use tool to grow traffic, make online sales, seamlessly handle orders and drive retention. Built for food entrepreneurs, built with taste.
- Promptwatch — PromptWatch is a platform designed for SEO professionals and digital marketers who want to stay ahead in the age of AI-driven search. As Generative AI engines like ChatGPT, Claude, and Perplexity increasingly influence how users discover information, PromptWatch helps businesses ensure their brand is visible and relevant within these AI-generatedanswers. Our tool enables users to monitor mentions of their brand across leading AI engines, uncover where and how their business is referenced, and identify optimization opportunities to improve visibility. By tapping into Generative Engine Optimization (GEO), PromptWatch empowers marketers to adapt their strategies beyond traditional search engines—ensuring their content gets surfaced in the conversations and answers that matter most. PromptWatch is your essential toolkit for thriving in the next wave of search.
redalpine is a thesis-driven vc with deep expertise in software and science. since 2006. we believe in the power of big ideas and in empowering game changers. we don't just invest, we co-create a better tomorrow. together with you.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A, Series B
- Geography: Germany, Switzerland, United Kingdom
Investor stats
- Total investments: 201
- Round size: Seed $1.6M–$13M; Series A $3.2M–$33M; Series B $16M–$125M
- Lead/follow: 38% lead, 62% follow
- Last fund: Likely still investing — raised $200M in 2024
Portfolio highlights
- microagi — Accelerating embodied AGI
- telli — A world where every interaction is worth having. https://t.co/Qa65ENaxKL
- Arlequin AI — Unlock actionable insights from complex social data to drive strategic decisions using our AI models.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Springboard Health Angels is a Berlin based Angel group to invest in early stage Digital Health startups
Show more...Investment focus
- Industry: Health Care, Medical, Software
- Stage:Seed, Pre-Seed
- Geography: Germany, United States, Switzerland
Investor stats
- Total investments: 25
- Round size: Seed $932k–$5.8M; Pre-Seed $400k–$3.8M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- Cellbyte — AI Agents for Pricing and Market Access Teams in the Pharmaceutical Industry.
- MedGlance AI — MedGlance AI is a pioneering HealthTech platform that transforms complex medical reports into intuitive, patient-friendly visual protocols. Utilizing advanced Generative AI and the NanoBanana 2 (gemini-3-flash) engine, we provide real-time anatomical visualizations to improve health literacy and patient outcomes. Our "Zero-Retention"protocol ensures total data privacy, making us a trusted partner for healthcare providers and individual patients alike. We are dedicated to ensuring Health Equity through accessible, visual-first medical communication
- Captain T Cell — Captain T Cell is a start-up project that develops T cell-based immunotherapies for cancer patients. The company identifies novel high-efficiency TCRs for the development of T cell immunotherapies. It focuses on CMC- and preclinical development for their lead candidates.
Backing early-stage startups that drive positive impact for people and planet
Show more...Investment focus
- Industry: E-Commerce, Health Care, Software
- Stage:Seed, Series A, Series B
- Geography: Germany, United Kingdom, Denmark
Investor stats
- Total investments: 92
- Round size: Seed $3.3M–$12M; Series A $5.6M–$35M; Series B $11M–$80M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — raised $152M in 2022
Portfolio highlights
- Averia — Averia is focused on geotechnical and environmental engineering. The company supports businesses in geotechnical engineering, hydrogeology, environmental technology.
- AssistMe — With a smart, adaptive and automated form of data processing and preparation, alea opens the way for future-proof, digitally supported everyday care. As an initial component of the AssistMe care platform, alea enables a contemporary, efficient care data culture for future intersectoral, networked processes and digitally supported teamwork. In theend, the aim is to effectively support care in times of a shortage of skilled workers through more self-determined content transparency - with complete personal autonomy and freedom of action and less redundancy & stress.Elderly Care will struggle in the next 10 years due to an increasing ageing population, fewer caregivers, more workload, stress, and manual documentation. All of that is a problem for the well-being of those in need of care. Furthermore, the incontinence management means large time and material expenses for caregivers. With the joint system, both companies can equip over 80 % of care recipients in care homes. An initial scientific study proved that the system could save 23 % of adult diapers and time while changing them. Together with significantly fewer leakages, the caregiver can reinvest the time gained in even higher quality care work. This ultimately has the potential to benefit care recipients in terms of quality of sleep and life. Digital functions for optimized care processesWith a very new smart sensor strip, we made leading quality adult diaper brands compatible with the digital possibilities of intelligent care technology of alea. The system reveals where care needs exist, but are not immediately visible, e.g. the urine status in the adult diaper which previously was not known until manually checked. The system transforms this initially hidden care and health data and converts it into digital, structured, immediately understandable real-time information for elderly care and its relevant stakeholders. All functionalities are based on the device alea sensor clip on smart Diaper products, which can be attached and changed in seconds. With just one quick click, caregivers turn the smart diaper into a ready-to-use digital care assistance system. With an optimal sensor position in the centre of the adult diaper and without direct skin contact. The alea hardware can generate highly valid information and make it available to care staff in real time through the mobile and web apps. The care-relevant information of alea includes the amount of urine, movements in the care bed for effective pressure ulcer prevention, fall detection and zone management. How caregivers, care homes & care recipients benefitOver 80 % of care home residents suffer from incontinence. This is a major challenge for everyone involved. The smart system solves issues for all care related audiences: Care recipients benefit from less time in full incontinence pads, but also benefit from fewer manual visual checks during bedtimes. In addition, there is a higher level of safety and prevention. By reducing time-consuming routine and visual checks on an as-needed basis. Caregivers can invest the time gained in other important or relevant care tasks. In this way, they can increase their self-determination in their work and thus their job satisfaction. Thanks to the significant savings in materials and costs, care home operators gain more planning security and can focus their business value creation even better on direct care for people in need of care. In this way, care homes can position themselves as more attractive employers for care staff because they have state-of-the-art digital equipment.With the Care. For the Care. The solution was developed and tested together with the care practice. With the IoT and future-proof platform approach, caregivers will benefit from additional functions in an established and accepted product setting. The system can be connected to various care documentation systems via open interfaces. The aim of the solution is not only to reduce the workload for all those involved in care. Care homes can also optimize teamwork and automate routine processes to support caregivers in the interests of people-centric care in the face of an increasing shortage of skilled staff. With the market entry, care homes can obtain information and order from us or one of our partners. While they order smart Diapers from our partners in the unit price context they are used to, alea Digital System comes as a software-as-a-service model. Without any additional initial costs, they can use all functions via personally provided hardware and software for each care recipient – for the most cost-efficient and needs-orientated use.
- Reformer Club — Reformer Club creates aesthetically designed studios for dynamic Reformer Pilates and personal training that make movement part of your lifestyle.
BioMedPartners is one of the leading European venture capital firms providing private equity and mezzanine financing to early- and mid-stage healthcare and human life science companies. They target the entire industry with special focus on pharmaceuticals, biotechnology, diagnostics and medical technology.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: Switzerland, Germany, France
Investor stats
- Total investments: 88
- Round size: Series A $5.3M–$31M; Series B $5.3M–$75M; Series C $5.3M–$47M
- Lead/follow: 34% lead, 66% follow
- Last fund: May invest from a new fund soon — raised $106M in 2018
Portfolio highlights
- T-CURX — T-CURX develops a new generation of T cells for personalized cancer immunotherapy, built on a proprietary platform that overcome challenges ...
- iDEL Therapeutics — iDEL Therapeutics is advancing a new class of cancer medicines by delivering therapeutic payloads directly into the cytosol of tumor cells through a unique, pan-cancer uptake mechanism.
- ImmunOs Therapeutics — ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
468 Capital is an investment firm that focuses on identifying and managing opportunities in various markets. The firm employs a systematic approach to investment analysis and portfolio management. It collaborates with a range of partners to support its investment strategies. The company serves industries including technology, healthcare, andrenewable energy.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Germany, Singapore
Investor stats
- Total investments: 229
- Round size: Seed $2.3M–$12M; Pre-Seed $500k–$3.8M; Series A $9M–$42M
- Lead/follow: 38% lead, 62% follow
- Last fund: Likely still investing — raised $400M in 2022
Portfolio highlights
- Relixir — Relixir is AI Generative Engine Optimization (GEO) assistant that maps, monitors and improves AI search rankings.
- Pally — Pally is an AI Agent for your network.
- ARC Intelligence — ARC Intelligence operates as a supplier of data systems driven by AI for small and medium-sized businesses.
Heartcore Capital invests in companies re-enchanting the world through technology.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, FinTech
- Stage:Seed, Series A, Series B
- Geography: Denmark, United States, Germany
Investor stats
- Total investments: 216
- Round size: Seed $1.2M–$12M; Series A $3.4M–$27M; Series B $9.5M–$58M
- Lead/follow: 28% lead, 72% follow
- Last fund: Likely actively investing — fresh fund, raised $179M in 2024
Portfolio highlights
- Capalo AI — We maximize the value of your energy storage systems. Now and in the future.
- PhaseTree — Materials design simulation company - PhaseTree ApS
- Everywear Games — Everywear Games is the world’s leading wearable game studio. The company was founded in 2014 by industry veterans from Remedy, Digital Chocolate and Rovio and it is the pioneer of smartwatch gaming. It’s award-winning Apple Watch launch title, Runeblade, has received worldwide recognition from press, fans and industry heavyweights and it’s gamesare consistently on top of global charts.
VF-Funds for innovative and scalable start-ups from the Rhineland Area, Germany
Show more...Investment focus
- Industry: Software, Health Care, Manufacturing
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Spain
Investor stats
- Total investments: 41
- Round size: Seed $1.5M–$5.8M; Pre-Seed $1.2M–$2.4M; Series A $5.4M–$28M
- Lead/follow: 68% lead, 32% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Octonomy — octonomy: AI-as-a-Service mit der neuen Generation von KI-Agenten. 80 % Zeitersparnis, 24/7-Support in 30+ Sprachen, live in 20 Tagen.
- Wakeline — Wakeline builds the missing half of AI: continual learning that adapts in operation, staying aligned as conditions change. Market Edge delivers adaptive day-ahead price forecasts for European BESS operators.
- specter automation — Construction is the second least digitized sector in the world with 96% of all data being unused. Although detailed planning data is created upfront, a lack of suitable digital tools prevents its transfer to the construction site. SPECTER’s web-based construction management software uniquely incorporates the core components of constructionplanning, reducing the organizational burden on construction management and helping to meet project timelines and budgets.
Cherry Ventures is an early-stage venture capital firm led by a team of entrepreneurs with experience building fast-scaling companies such as Zalando and Spotify. The firm backs Europe's boldest founders, usually as their first institutional investor, and supports them in everything from their go-to-market strategy and the scaling of theirbusinesses. Cherry Ventures has previously invested in the seed stage of over 50 companies across Europe, including FlixBus, Auto1 Group, Infarm, Rows, Forto, and TourRadar. Cherry Ventures is based in Berlin and invests across Europe with operations in London, Paris, and Stockholm.
Show more...Investment focus
- Industry: Software, Information Technology, Financial Services
- Stage:Seed, Series A, Series B
- Geography: Germany, United Kingdom, United States
Investor stats
- Total investments: 293
- Round size: Seed $1.9M–$14M; Series A $7.3M–$44M; Series B $14M–$117M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely actively investing — fresh fund, raised $500M in 2025
Portfolio highlights
- Resolutiion — Resolutiion provides AI-powered software for managing commercial conflict, delivery risk, and business relationship performance. The platform supports organizations with dispute detection, workflow automation, contract monitoring, issue resolution, and operational risk management across customers, suppliers, workforce teams, and commercialpartnerships. Its system uses AI-driven analysis to identify relationship friction, monitor delivery performance, and support structured resolution processes. Resolutiion also provides commercial intelligence tools, reporting, and collaboration features for enterprise delivery and governance management.
- Bits Technology — Bits Technology connects data sources & orchestrates workflows for financial tech services.
- Black Forest Labs — Official Account: https://t.co/iF047jr0Yg @bfl_ai
Picus Capital is an early-stage technology investment firm with a long-term investment philosophy. We work together with daring technology companies to build successful, global companies challenging the status quo and shaping tomorrow.
Show more...Investment focus
- Industry: Financial Services, Software, FinTech
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 451
- Round size: Seed $1.6M–$11M; Pre-Seed $563k–$4.5M; Series A $3.9M–$33M
- Lead/follow: 19% lead, 81% follow
- Last fund: Likely still investing — raised $140M in 2024
Portfolio highlights
- Enpal — Kostenlose Planung von Solaranlagen. Gewinnbringende & schnelle Umsetzung von Photovoltaikanlagen inklusive professionelle Installation & Netzanschluss. Zum Festpreis!
- Lightbase — An always up-to-date view of your entire IT ecosystem for faster decisions and confident transformation at scale
- Spot My Energy — The uptake of PV, EVs, home storage, and heat pumps leads to a gigantic need for digital and intelligent metering and for the integration of millions of...
Target Global is a prominent European technology investment firm with a significant presence in the venture capital landscape, boasting over €3 billion in assets under management. The firm operates out of key tech hubs including London, Berlin, Tel Aviv, and Abu Dhabi, and has a rich portfolio featuring some of Europe's most successful techcompanies such as Revolut, Auto1, Copper, Delivery Hero, Docplanner, and Rapyd.Founding and GrowthTarget Global was established in 2015 by Shmuel Chafets and Yaron Valler, who brought a wealth of experience from their tenure at Hasso Plattner Ventures. Their professional partnership dates back 15 years to their time at Giza Venture Capital, a trailblazer in Israel's investment ecosystem, where they honed their investment acumen and industry foresight.Investment Philosophy and ImpactTarget Global stands out in the European tech industry for its diverse team and its ability to identify and capitalize on unique opportunities. The firm's knack for recognizing potential in the early stages of Germany's tech economy led to the emergence of several unicorns in the 2010s. As the European tech industry evolves, Target Global remains at the forefront, seeking out innovative companies like Robovision, Saleor, and Finom. These recent investments reflect the firm's commitment to supporting cutting-edge technology and business models.Fundraising SuccessesTarget Global's fundraising prowess is evident in its six investment funds, which have collectively raised significant capital. The funds range from Early Stage Funds, focusing on nascent startups, to Growth Funds that support more mature companies scaling their operations. The firm's co-investment strategy has led to over €1 billion in capital deployment across a diverse array of partnerships.Backing and AchievementsWith the backing of investors such as FERI, UBS, Allianz X, Mubadala, and Hermes GPE, Target Global has cemented its reputation as a trusted and successful investment firm. Its portfolio spans over 140 companies at various development stages, with a focus on those targeting trillion-dollar markets.Just a few of the many notable companies in the firm’s portfolio include:- Tarabut, MENA’s leading open banking platform, which was recently featured in Forbes Middle East’s list of Top 50 Fintech Companies.- Flo Health, an AI-driven women’s health product, which is the world’s top health and fitness app by downloads.- Robovision, an easy-to-use AI-driven computer vision platform for users to develop their own deep-learning-based solutions.- Enter, a German company that helps homeowners and businesses reduce their carbon footprint.Target Global's track record includes support for 15 unicorn companies, over 20 exits, and 7 IPOs, showcasing its ability to drive growth and success in the European tech ecosystem. The team, comprised of individuals with founder and operator backgrounds, continues to pursue exceptional opportunities to expand the firm's portfolio and influence.Target Global's journey from its inception to its current status as a key player in European venture capital is marked by strategic investments, a commitment to diversity, and a deep understanding of the tech industry's dynamics. With a clear vision for the future, Target Global is poised to continue its role in shaping the next wave of European tech giants.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Series A, Seed, Series B
- Geography: Germany, United States, Israel
Investor stats
- Total investments: 241
- Round size: Seed $2M–$19M; Series A $3.8M–$34M; Series B $11M–$100M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — raised $214M in 2022
Portfolio highlights
- Enter — baupal seeks to democratize sustainable and customized architecture, making design, energy assessments, permitting and cost evaluations more accessible and straightforward for private builders and smaller construction projects. baupal is an online building application service that takes advantage of digital processes and efficient team structuresto streamline design, planning and permitting processes for a range of small-scale projects.baupal was established in December, 2020 in Berlin, Germany.
- Alta — Alta leverages data and AI to drive business growth 24/7.
- Nimble Way — Automate data collection with real-time pipelines. Power AI & BI with structured, cloud-integrated data for accurate insights & growth.
Flixbus' founders' family office
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Israel, Luxembourg
Investor stats
- Total investments: 53
- Round size: Seed $1.4M–$15M; Pre-Seed $543k–$3.8M; Series A $8.5M–$34M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Augur — Augur provides advanced sensor fusion and machine learning solutions for security applications.
- R3 Robotics — Circu Li-ion is a European battery upcycling startup. Our vision is to fight the climate crisis by maximising the lifecycle of each Lithium-ion cell.In 2021, we have embarked on our journey to enable a circular lifecycle to batteries in three steps: the dismantling of batteries, the diagnostic of cells and the reassembly based on reusedcomponents - automated and at scale .We provide our technology to leading players in the space of micromobility, q-commerce & delivery, hardware manufacturing and recycling. Our Machine-as-a-Service solution offers a possibility to give their used batteries a second life through upcycling instead of recycling - saving money and the planet.
- Proxima Fusion — We are a European fusion energy startup pursuing the clearest path to grid deployment.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!At better ventures we invest in early-stage founders who aim to change our world for the better.
Show more...Investment focus
- Industry: Software, Food and Beverage, E-Commerce
- Stage:Pre-Seed, Seed, Series A
- Geography: Germany, Switzerland
Investor stats
- Total investments: 54
- Round size: Seed $1.5M–$6.9M; Pre-Seed $1.1M–$3M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- Porelio — Porelio is an environmental technology that provides purification technologies for water and industrial chemicals.
- Enzo — Enzo is a Heidelberg based InsurTech startup offering modern and smart insurance coverage for homeowners. Instead of just reacting to claims, Enzo takes a proactive customer-focused approach to prevent damages from happening at all. Thus, Enzo is leading a paradigm shift in a €100+ billion market that has barely improved customer experience forover 100 years. Our Goal is to become Europe's smartest homeowners insurance.
- Tokura — Tokura focused on redesigning outpatient surgery (Ambulantes Operieren) through an integrated system of specialised facilities, experienced teams, and automated technology.
The Redstone team is an international and diverse group of serial entrepreneurs, investors, investment professionals, tech analysts and data scientists.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Finland, Switzerland
Investor stats
- Total investments: 179
- Round size: Seed $460k–$7.8M; Pre-Seed $1M–$4.4M; Series A $1.7M–$17M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely actively investing — fresh fund, raised $29M in 2026
Portfolio highlights
- FermLabs — Ferm Labs ingredient startup specializing in proprietary, high-yield bioprocessing platforms.
- LimX Dynamics — Zhuji Dynamics is a general-purpose footed robot company that focuses on the R&D and manufacturing of sports intelligence and footed robots
- Zhuji Dynamics — Zhuji Dynamics is a general-purpose footed robot company that focuses on the R&D and manufacturing of sports intelligence and footed robots
BONVENTURE empowers impact-driven founders and impact investors across DACH with capital, expertise, and a strong network for true impact and return.
Show more...Investment focus
- Industry: Health Care, Software, SaaS
- Stage:Seed, Series A
- Geography: Germany, Austria, Estonia
Investor stats
- Total investments: 46
- Round size: Seed $980k–$11M; Series A $5.1M–$19M
- Lead/follow: 37% lead, 63% follow
- Last fund: Likely still investing — raised $55M in 2022
Portfolio highlights
- BIOWEG — Founded in Germany in 2019, Bioweg is a purpose-driven company, matches BioInnOvation to business problems. Their research combine biotechnology, material science, and molecular simulation learning to develop and sell B2B advanced sustainable and bio-based high-performance ingredients. Their ingredients are 100% animal-free, globally scalable, andsustainably manufactured with green chemistry. The company partners with results-driven, forward-thinking companies and consumer brands with global reach in cosmetics, personal care, agricultural technology, and food/beverage sectors. Bioweg's innovative zero-waste circular process uses food industry waste as feedstock to produce bio-based microbeads, rheology modifiers and hydrocolloids that are completely free of microplastics and comply with the new ECHA regulation.
- Resourcify — Resourcify is on a mission to enable a zero-waste future!!! Through the digitisation of daily operations, our recycling platform enables all businesses to manage, track, and improve their recycling while having less administration, and saving up to 40% of the costs compared to conventional waste management.Resourcify is trusted by thousands ofthe most leading companies & organisations around the globe including : Cargill, McDonalds, Hornbach, Johnson & Johnson, Edeka, Frankfurt Airport, UK Bonn, and more! Our award-winning recycling platform improves the approach to sustainability as a best practice and enhances the recycling processes to reduce waste.
- Vivira — Vivira Health Lab focuses on making physical rehab programs available to everyone.
Capacura is reinventing the venture capital market so that more start-ups get access to capital, knowledge, processes and solutions.
Show more...Investment focus
- Industry: Health Care, Recycling, Software
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: Germany
Investor stats
- Total investments: 26
- Round size: Seed $505k–$2.9M; Pre-Seed $889k–$963k
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- odacova — Odacova is a SaaS company that provides individualized nutrition for corporate cafeterias and employee eating, utilizing web, Android, and iOS platforms.
- Foom — The foom technology extracts valuable fertiliser from organic waste - on site and in record time
- Everwave — Everwave is a social enterprise that focuses on preventing plastic pollution in rivers and oceans.
Coparion provides venture capital to accelerate momentum and growth. With a currently active fund of EUR 275 million, Coparion has the means to do so.Coparion supports entrepreneurial vision with know-how, but without intervening in daily business operations. Thanks to in-depth experience in venture capital and in building companies, the Coparionteam discerns potential and opens up new perspectives. Coparion has the substance, tenacity, and creativity required to mutually manage difficult situations successfully.Coparion only invests with co-investors. The fund invests up to EUR 15M per company, usually in several financing rounds of EUR 0.5-8M each. The investment focus is on German companies in the start-up and early growth phases. Coparion is based in Cologne and Berlin.
Show more...Investment focus
- Industry: Software, SaaS, FinTech
- Stage:Series A, Seed, Series B
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 97
- Lead/follow: no public data
Portfolio highlights
- Finoa — Finoa is the leading European crypto-asset management platform, empowering businesses and institutions to engage with crypto safely and intuitively.
- Protembis — ProtEmbo is designed to be a simple and reliable solution for one of the most feared complications during TAVR.The advent of transcatheter treatments for valvular heart disease has been a major revolution in the care of patients with disabilities or intercurrent illnesses that precluded undergoing stressful open cardiac surgical procedures.Nonetheless, in spite of ongoing improvements in TAVR procedures and outcomes, the occurrence of cerebrovascular events represents a significant morbidity of TAVR.Protembis was founded based on the vision to reduce the risk of cerebrovascular events, thereby improving outcomes and making TAVR even safer – especially in light of TAVR shifting to younger and lower-risk patients. The ProtEmbo System is an adjunctive device used during TAVR and removed following completion of valve implantation. The ProtEmbo is an intra-aortic filter device that is designed to deflect embolic material arising during TAVR away from the cerebral circulation.
- Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
Amino Collective is an institutional venture capital firm investing at seed stage in health and bio companies. They help bring life-changing ideas to life by backing, connecting, and advancing our collective of entrepreneurs and scientists. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, lifescience, and synthetic biology.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 46
- Round size: Seed $2.4M–$14M; Pre-Seed $125k–$7.8M; Series A $12M–$37M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Calibre — Diagnostic testing, clinicians, and AI working together to help you deeply understand your health and how to improve it.
- Modern Relay — Modern Relay provides context graph for enterprise AI.
- Tandem Health — Focus on providing care, while Tandem helps you easily write medical notes directly after the patient consultation.
We have been investing at the frontier of technology and science for over 30 years. We know what it takes to succeed.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Series B
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 96
- Round size: Series A $2M–$12M; Series B $5.1M–$30M
- Lead/follow: 42% lead, 58% follow
- Last fund: May invest from a new fund soon — raised $90M in 2016
Portfolio highlights
- SIRION BIOTECH — Viral Vector Technology as key enabler for innovative therapeutics. Viral vectors are a tool commonly used by molecular biologists to deliver genetic material into cells. This technique enables research of gene function and innovative therapeutics designed to correct defective genes and cancer. These technologies also assist in the discovery ofnew drug, food and cosmetic compounds. SIRION is a global leader in viral vector technology for gene modification of mammalian cells. Along with custom services, the company stands ready to outlicense its unique technologies. An initial target currently being pursued by one of SIRION's partners is a gene therapeutic for cervical cancer. The company started business in 2007 and since then has been changing the paradigm of viral vector supplies. Specifically, all commonly applied vector types are now available within a matter of weeks - adenovirus, adeno-associated virus (AAV) and lentivirus - and a full range of virus related services is at your fingertips spanning from particle production to virus driven cell modelling, all at highest titers and in quantities required for preclinical, clinical and animal testing.The company is easily accessible with presence in Munich, Tokyo, New Hampshire and Tel Aviv. Commercial arrangements range from fee-for-service over exclusive rights on single clones all the way to milestone & licensing arrangements. The business model proves successful: an annual 70% growth since 2007 and experienced in more than 500 projects for both the academic and industry sector.The company is privately held and has over the years raised funds from 8 investors both private and government. In order to support further growth and to benefit from technology development in this exciting industry, the company welcomes new investors. Please contact Management for further information about the company and its future plans.
- CryoTherapeutics — CryoTherapeutics is focusing on the development, demonstration of clinical benefit, and early-stage commercialization of a proprietary cryotherapy system for use in the treatment of coronary artery disease that causes heart attacks. The safety and efficacy of cryoenergy in the cardiovascular system has been demonstrated and CryoTherapeutics intendsto extend the benefits of cryoenergy to the problem of diseased coronary arteries.
- Chundsell Medicals — Chundsell Medicals AB was founded in 2007 as a spin off from Karolinska Institutet, Solna, in order to commercialize the research results of Chunde Li and his group on prostate cancer genomics. The first product: The Prostatype® Test System can assess prostate cancer aggressiveness in conjunction with currently used clinical parameters. TheProstatype® Test System measures the expression pattern of three selected and specific prostate cancer embryonic stem cell genes in tumor cell tissue specimens. These expression patterns together with a group of a selected number of known clinical parameters will help the health care professional to predict the disease outcome, the overall survival as well as cancer specific survival of patients.
Founded in 1997, Earlybird is a pan-European VC investor backing tech-enabled companies and investing in their growth and development. Funds include Earlybird, Earlybird Health, Growth Opportunities.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Seed, Series B
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 394
- Round size: Seed $1.5M–$14M; Series A $4.4M–$35M; Series B $6M–$75M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely actively investing — fresh fund, raised $422M in 2026
Portfolio highlights
- Avrea — Avrea is the CI/CD platform built for the age of AI, helping teams ship software faster, more often, and with higher quality.
- Hilo — Get stress-free readings round the clock with Hilo's clinically validated blood pressure monitor. Learn more
- Neuracore — The robot skill creation engine: collect demonstrations, curate datasets, train imitation and reinforcement learning policies, and deploy them on real robots, all on one platform.
Possible Ventures backs ambitious teams building frontier technology to positively impact society. We invest globally in the early stages, actively supporting founders via our collective of global entrepreneurs.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany, Australia, United States
Investor stats
- Total investments: 164
- Round size: Seed $1.6M–$10M; Pre-Seed $549k–$3.8M; Series A $9.7M–$47M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- EntryLevel — Learn in an affordable, peer-driven environment over 6 weeks with mentors from top companies across the world such as Atlassian, Wise and more.
- Sizable energy — Sizable Energy addresses the critical need for secure, affordable, and sustainable energy storage. Sizable Energy patented technology and straightforward design extends pumped hydro deployment to any offshore location with a depth of at least a few hundred meters. By leveraging a novel, modular, and easily deployable method, we utilize thegravitational potential of a solution 20% heavier than seawater, like saturated sea salt brine, within seawater.
- Koala Go — Your student's favorite online classroom. 24/7 live support. Co-browser. Gamified teaching environment. Worldwide invoicing. Interactive whiteboard.
BM H Beteiligungs-Managementgesellschaft Hessen mbH operates as an investment arm of Landesbank Hessen-Thüringen Girozentrale.
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany
Investor stats
- Total investments: 48
- Round size: Seed $605k–$6.9M; Pre-Seed $609k–$1.5M; Series A $1.1M–$9.3M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Eduneon — Eduneon is developing a digital platform to help schools and municipalities plan and manage digital educational change in a systematic and ongoing manner. It uses software solutions to deliver sustainable and pedagogically meaningful media education.
- Verrano — Verrano specializes in enhancing the regional root vegetables. It consciously takes a different approach than many other plant-based market firms.
- QuoIntelligence — Our finished intelligence will significantly reduce your operational risks and allow you to make informed security decisions.
Health Care VC funding in Germany at a glance
Stats across 2.1k deals from 1.7k investors.
Access all 1686 VC funds in Germany Health Care startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Health Care VC Funds in Germany investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 1686 VC funds investing in Germany Health Care startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!